Ionis Pharmaceuticals (IONS) Total Liabilities (2009 - 2026)

Ionis Pharmaceuticals' Total Liabilities history runs 18 years deep, the most recent figure standing at $3.0 billion for Q1 2026.

• In Q1 2026, Total Liabilities rose 26.58% year-over-year to $3.0 billion; the TTM figure through Mar 2026 stood at $3.0 billion (up 26.58% YoY), while the FY2025 annual figure was $3.0 billion, up 25.65% from the prior year.
• Total Liabilities was $3.0 billion for Q1 2026 at Ionis Pharmaceuticals, down from $3.0 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $3.0 billion in Q4 2025 to a low of $1.8 billion in Q1 2022.
• Historically, Total Liabilities has averaged $2.4 billion across 5 years, with a median of $2.4 billion in 2024.
• The sharpest annual moves came in 2023 and 2024: Total Liabilities jumped 43.28% in 2023, then dropped 7.63% in 2024.
• A 5-year view of Total Liabilities shows it stood at $2.0 billion in 2022, then surged by 32.76% to $2.6 billion in 2023, then retreated by 7.22% to $2.4 billion in 2024, then increased by 25.65% to $3.0 billion in 2025, then decreased by 2.51% to $3.0 billion in 2026.
• The last three Total Liabilities figures came in at $3.0 billion (Q1 2026), $3.0 billion (Q4 2025), and $2.4 billion (Q3 2025), per Business Quant data.